Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

Purdue Pharma ... to future lawsuits. State, municipal and local governments are expected to receive most of the settlement proceeds for opioid treatment and mitigation programs, while some of the ...

Purdue Pharma and the members of the Sackler family who own the company agreed in principle to pay a $7.4 billion settlement to resolve thousands of lawsuits over their alleged role in the opioid ...

The Sackler family and Purdue Pharma agreed to pay $7.4 billion to settle lawsuits over the toll of the powerful prescription ...

A group of 15 states have reached a tentative new deal that would require them to set aside hundreds of millions of dollars from the settlement in a legal-defense fund for the family.

Purdue Pharma's earlier settlement plan included a $6 billion contribution from the Sacklers in exchange for immunity from all civil opioid claims, even though the family itself did not file for ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... They’ve continued to deny claims of any wrongdoing. Collectively, family members have been estimated ...

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half of what was originally anticipated before a Supreme Court decision put ...